Validation of the two best models to predict "benign" pathohistology in patients with advanced nonseminomatous germ cell tumors (NSGCT) undergoing postchemotherapy retroperitoneal lymph node dissection (PC-RPLND)

Nestler, T; Paffenholz, P; Baessler, B; Hellmich, M; Hiester, A; Nini, A; Pfister, D; Albers, P; Heidenreich, A

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (6):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索